Report cover image

Renal Anemia Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published Oct 07, 2025
SKU # BIS20455608

Description

Global Renal Anemia Market, Analysis and Forecast: 2025-2035

The global renal anemia market is experiencing steady expansion, supported by advancements in therapeutic modalities, increased diagnostic precision, and growing investment in healthcare infrastructure across the U.S., Europe, and emerging economies. Expansion of advanced treatment options, including erythropoiesis-stimulating agents (ESAs), iron supplementation regimens, and novel oral hypoxia-inducible factor prolyl‑hydroxylase inhibitors (HIF‑PHIs), is significantly reshaping the global renal anemia market landscape. As awareness rises regarding the complications of untreated renal anemia, such as severe fatigue and poor quality of life, demand for effective, patient‑friendly therapies continues to escalate.

Innovations in therapeutic products, and improved iron formulations are key drivers behind the global renal anemia market growth. The growing adoption of non‑invasive oral administration routes alongside injectable options expands treatment accessibility and convenience.

Heightened focus on early diagnosis and management in both developed regions, such as the U.S. and Europe, and in emerging markets is a major growth catalyst for the global renal anemia market. Rising healthcare investment and expanding renal care programs are supporting wider access to effective therapies. In addition, the increasing geriatric population, including those with chronic kidney disease, has elevated the prevalence of renal anemia, fueling demand for targeted treatments.

Despite progress, the global renal anemia market faces challenges, including high costs of advanced therapies and side-effect concerns associated with long-term use. Nonetheless, ongoing research and development efforts, alongside the introduction of cost-effective biosimilars and oral treatment alternatives, are poised to address access barriers and drive further market penetration.

Looking ahead, the global renal anemia market is projected to be driven by expanding therapeutic portfolios, improved diagnostic capabilities, and rising demand for accessible anemia care solutions.

The global renal anemia market is poised for steady growth, supported by the rising prevalence of chronic kidney disease and sustained investments in therapeutic infrastructure across the U.S., Europe, and emerging markets. Expansion is being fueled by advanced treatment modalities, including long‑acting erythropoiesis‑stimulating agents, oral hypoxia‑inducible factor prolyl‑hydroxylase inhibitors (HIF‑PHIs), and enhanced access to supportive care through improved reimbursement frameworks. Innovative oral therapies are enhancing ease of administration and adherence.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. Global Renal Anemia Market: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.2 Epidemiological Analysis
1.3 Regulatory Landscape
1.4 Pipeline Analysis
1.5 Market Dynamics
1.5.1 Market Drivers
1.5.1.1 Impact Analysis
1.5.2 Market Restraints
1.5.2.1 Impact Analysis
1.5.3 Market Opportunities
1.5.3.1 Impact Analysis
2. Global Renal Anemia Market, by Region, $Million, 2024-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Renal Anemia Market (by Country)
2.1.2.1.1 U.S.
2.1.2.1.2 Canada
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Renal Anemia Market (by Country)
2.2.2.1.1 Germany
2.2.2.1.2 France
2.2.2.1.3 U.K.
2.2.2.1.4 Spain
2.2.2.1.5 Italy
2.2.2.1.6 Rest-of-Europe
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Renal Anemia Market (by Country)
2.3.2.1.1 Japan
2.3.2.1.2 Rest-of-Asia-Pacific
2.4 Rest-of-the-World
2.4.1 Market Dynamics
2.4.2 Market Sizing and Forecast
3. Global Renal Anemia Market - Competitive Benchmarking & Company Profiles
3.1 Key Strategies and Development
3.1.1 Mergers and Acquisitions
3.1.2 Partnership, Alliances and Business Expansion
3.1.3 New Offerings
3.1.4 Regulatory Activities
3.1.5 Funding Activities
3.2 Company Profiles
3.2.1 Amgen Inc.
3.2.1.1 Overview
3.2.1.2 Top Products/Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
3.2.2 Sandoz Group AG
3.2.2.1 Overview
3.2.2.2 Top Products/Product Portfolio
3.2.2.3 Top Competitors
3.2.2.4 Target Customers
3.2.2.5 Key Personnel
3.2.2.6 Analyst View
3.2.3 Pfizer Inc.
3.2.3.1 Overview
3.2.3.2 Top Products/Product Portfolio
3.2.3.3 Top Competitors
3.2.3.4 Target Customers
3.2.3.5 Key Personnel
3.2.3.6 Analyst View
3.2.4 GlaxoSmithKline Plc
3.2.4.1 Overview
3.2.4.2 Top Products/Product Portfolio
3.2.4.3 Top Competitors
3.2.4.4 Target Customers
3.2.4.5 Key Personnel
3.2.4.6 Analyst View
3.2.5 Akebia Therapeutics
3.2.5.1 Overview
3.2.5.2 Top Products/Product Portfolio
3.2.5.3 Top Competitors
3.2.5.4 Target Customers
3.2.5.5 Key Personnel
3.2.5.6 Analyst View
3.2.6 Astellas Pharma Inc.
3.2.6.1 Overview
3.2.6.2 Top Products/Product Portfolio
3.2.6.3 Top Competitors
3.2.6.4 Target Customers
3.2.6.5 Key Personnel
3.2.6.6 Analyst View
3.2.7 Others
4. Research Methodology
List of Figures
Figure: Global Renal Anemia Market Coverage
Figure: Global Renal Anemia Market Key Trends, Impact Analysis, 2024-2035
Figure: North America Renal Anemia Market, $Million, 2024-2035
Figure: Europe Renal Anemia Market, $Million, 2024-2035
Figure: Asia-Pacific Renal Anemia Market, $Million, 2024-2035
List of Tables
Table: Market Snapshot
Table: Global Renal Anemia Market (by Region), $Million, 2024-2035
Table: Global Renal Anemia Market, Dynamics Impact Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us